title: Evolutionary Precision Medicine: A Role for Repeat Epidermal Growth Factor Receptor Analysis in ALK-Rearranged Lung Adenocarcinoma?
authors.affiliation: University College London Cancer Institute and The Francis Crick Institute, London, United Kingdom.
authors.forename: Nicolai Juul
authors.initials: NJ
authors.lastname: Birkbak
authors.affiliation: University College London Cancer Institute and The Francis Crick Institute, London, United Kingdom.
authors.forename: Crispin T
authors.initials: CT
authors.lastname: Hiley
authors.affiliation: University College London Cancer Institute and The Francis Crick Institute, London, United Kingdom charles.swanton@crick.ac.uk.
authors.forename: Charles
authors.initials: C
authors.lastname: Swanton
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology*; D008297:Male; D009154:Mutation; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*
chemical_list: D015514:Oncogene Proteins, Fusion; D066246:ErbB Receptors; D020794:Receptor Protein-Tyrosine Kinases